Skip to content

Traditional Chinese Medicine for Pandemic H1N1 Influenza: A Randomized Controlled Trial

Traditional Chinese Medicine for Pandemic H1N1 Influenza: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000779
Enrollment
Unknown
Registered
2010-02-10
Start date
2009-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pandemic H1N1Influenza

Interventions

GroupB:Chinese herbal medicines
Group A:Western therapy

Sponsors

Guangdong Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >=6 years old; 2. Patients diagnosed as mild Influenza (H1N1) including suspected cases, clinical diagnosis and confirmed by virology cases according to the criteria of WHO. Voluntarily participate this trial and sign the Inform consent; 3. Disease course was within 48 hours; 4. Temperature >=37.5 degree C.

Exclusion criteria

Exclusion criteria: 1. Severe and critically disease, multiple organ failure have emerged; 2. Patients with psychiatric disease; 3. Patients received influenza H1N1 vaccines; 4. Patients with complications or pregnancy.

Design outcomes

Primary

MeasureTime frame
Incidence of complications;Time to alleviation of symptom;

Secondary

MeasureTime frame
Negative rate of influenza virus detection;incidence of developing to severe influenza;Time of fever clearance;Direct coast of medical care;

Countries

China

Contacts

Public ContactChuanjian Lu
luchuanjian888@vip.sina.com+86 20 81887233-31223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026